If confirmed, Robert F. Kennedy Jr. could redefine vaccine policy, drug approvals, and food regulations, but the extensive bureaucratic processes complicate that ambition.
Experts express concern over potential shifts in federal health priorities, with a focus pivoting toward chronic disease and environmental health rather than infectious diseases.
Kennedy’s push for increased transparency may lead to more rigorous scrutiny of vaccine safety data and appoint individuals who align with his health philosophies.
Upcoming reauthorization talks for the FDA present an opportunity for RFK Jr. to challenge the relationship between regulators and the industries they oversee.
Collection
[
|
...
]